When I say "historic" for BMY I'm not talking ATH but the stock's encroaching on an area that has been tested 3 times being rejected each time. This is the 236 fib area using 2016's high as the top anchor. It's been 5 years since BMY traded well above this area. But with the way attention is being placed on immunotherapy stocks, it could be something to keep in...
MRK is back in this 382-236 fib range with both lining up pretty tightly with the current levels on the chart. 382 is a bit looser and more of a pivot area, for now, that's been a magnet for the stock over the last few weeks. Meanwhile, 236 was tested a few times and MRK was rejected each time. With the last update on Keytruda, it's going to be interesting to see...
the structure looks obvious 3-3-3 within a larger 3 wave corrective structure from Merck's ATH
I Hate Trading Pharma But... MRK BUYZONE = 74 - 76 Cost Avg Down (CAD) = 72 - 70 1st Target = 79 2nd Target = 82 3rd Target = 86 HODL Target = ATH ______________________________________________________________________________________________________________________ This content is for informational, educational and entertainment purposes only. This is not in...
Merck & Co, Inc. provides healthcare solutions worldwide. The company offers treatments for cardiovascular disease, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal infections, fungal infections, insomnia and inflammatory diseases; neuromuscular blocking agents; cholesterol-modifying drugs; and vaginal contraceptive and antibacterial...
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric...
When the first ABC correction was over we saw the bearish move. Now a smaller ABC correction may be finished and we can expect the next move. I will keep updating this chart if necessary. Comment, like follow for more accurate ideas. Thank you
My current waves on $MRK would love some feedback, this catalyst and original chart was brought up originally by @tomikazi It broke out of the downtrend channel and now is in wave 1. Has a catalyst on Wednesday 1/20/21 PDUFA VII Decision for MRK's Vericiguat: Merck Seeks Approval For Heart Failure Drug Company: Merck & Co., Inc. (NYSE: MRK) Type of...
NYSE:MRK Possible Scenario: LONG Evidence: Price Action This is my idea and could be wrong 100%.
Monthly Uptrend Weekly Uptrend Daily range with no clear TP and orientirs Trade possibe but with tight SL and speculative. Wait for formation
MERCK (MRK), D1: Support line + Side of Bollinger bands + Hidden divergence + 2 Hammers
MERCK AND ALL DRUGS ARE NOW SETUP TO RALLY SHARP ONCE AGAIN i HAVE NOW MOVED TO A 85% NET LONG MRK AS OF THIS POST LOOKING FOR A VERY SHARP AND FAST RALLY OVER THE NEXT 20 TD
see full chart at www.tradingview.com Gild Entry $62 area Target 1 $67 Target 2 $71 stoploss $59 Why this play? Trump used Gild's drug as part of his treatment, if he pulls thru with a full recovery. they will probably start pumping the news about this company and it'll finally have enough momentum to move back to the upside. What is Gild? Gilead Sciences,...
MERCK bullish pattern and trend. May take some days, so possible pullback and bounce on the lower support (green line). Could also channeling sideways, who knows. Difficult to lose with a warp speed candidate anyway. BUY ON FRIDAY! PT:87 at least Stop if breaks green line. Covid/Trump play. $JNJ $MRK $ABT
see full chart at www.tradingview.com GSK Entry $39.70 Target 1 $42.45 Target 2 $45.50 Target 3 $48 stoploss 38.70 Why this play? There are 4 general approaches to the Covid vaccine. 1.A "killed" coronavirus that will get recognized as foreign matter in the blood. (Sinovac/Dynavax) 2.Coronavirus proteins themselves, produced industrially in outside cell...